David C. Bean
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 16
-
- Escherichia coli research studies 3
- Co-authors
- D. Krahé (2 shared papers)David W. Wareham (13 shared papers)David M. Livermore (2 shared papers)Lucinda M. C. Hall (2 shared papers)Lara Wakeling (3 shared papers)Stephen R. Giddens (1 shared paper)Mike R. Millar (2 shared papers)Enid Hennessy (1 shared paper)
- Journals
- Journal of Antimicrobial Chemotherapy (6 papers)Journal of Clinical Microbiology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Annals of Clinical Microbiology and Antimicrobials (2 papers)mBio (1 paper)
- Partner nations
- AustraliaUnited KingdomNew Zealand
In The Last Decade
David C. Bean
37 papers receiving 885 citations
Peers
Comparison fields: 5 of 91
- Molecular Medicine 396
- Applied Microbiology and Biotechnology 75
- Endocrinology 144
- Clinical Biochemistry 78
- Pollution 127
Countries citing papers authored by David C. Bean
This map shows the geographic impact of David C. Bean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Bean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Bean more than expected).
Fields of papers citing papers by David C. Bean
This network shows the impact of papers produced by David C. Bean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Bean. The network helps show where David C. Bean may publish in the future.
Co-authors
The 25 scholars most cited alongside David C. Bean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 143 | |
| 2 | 2021 | 116 | |
| 3 | 2008 | 109 | |
| 4 | 2005 | 96 | |
| 5 | 2008 | 75 | |
| 6 | 2006 | 54 | |
| 7 | 2006 | 45 | |
| 8 | 2017 | 43 | |
| 9 | 2016 | 32 | |
| 10 | 2016 | 18 | |
| 11 | 2023 | 17 | |
| 12 | 2008 | 15 | |
| 13 | 2002 | 15 | |
| 14 | 2005 | 15 | |
| 15 | 2006 | 15 | |
| 16 | 2006 | 14 | |
| 17 | 2022 | 12 | |
| 18 | 2020 | 10 | |
| 19 | 2020 | 10 | |
| 20 | 2019 | 8 |
About David C. Bean
David C. Bean is a scholar working on Molecular Medicine, Endocrinology, Food Science, Infectious Diseases and Microbiology, having authored 37 papers that have together received 936 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (16 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Pneumonia and Respiratory Infections (4 papers), Salmonella and Campylobacter epidemiology (4 papers), Probiotics and Fermented Foods (4 papers), Escherichia coli research studies (3 papers), Microbial infections and disease research (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). The work is most often cited by research in Molecular Medicine (396 citations), Applied Microbiology and Biotechnology (75 citations), Endocrinology (144 citations), Clinical Biochemistry (78 citations) and Pollution (127 citations). David C. Bean has collaborated with scholars based in Australia, United Kingdom and New Zealand. Frequent co-authors include D. Krahé, David W. Wareham, David M. Livermore, Lucinda M. C. Hall, Lara Wakeling, Stephen R. Giddens, Mike R. Millar, Enid Hennessy, John David Klena and Lynette M. Phee. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy, Annals of Clinical Microbiology and Antimicrobials and mBio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.